Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.
- DOI
- 10.21037/atm-22-5632
- Published
- 2022 Dec
- Container
- Annals of translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/atm-22-5632,
title = {Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.},
author = {Zhang C and Zhu W and Meng Q and Lian N and Wu J and Liu B and Wang H and Wang X and Gu S and Wen J and Shen X and Li Y and Qi X},
year = {2022},
journal = {Annals of translational medicine},
doi = {10.21037/atm-22-5632},
url = {https://doi.org/10.21037/atm-22-5632}
}RIS
TY - JOUR TI - Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis. AU - Zhang C AU - Zhu W AU - Meng Q AU - Lian N AU - Wu J AU - Liu B AU - Wang H AU - Wang X AU - Gu S AU - Wen J AU - Shen X AU - Li Y AU - Qi X PY - 2022 JO - Annals of translational medicine DO - 10.21037/atm-22-5632 UR - https://doi.org/10.21037/atm-22-5632 ER -
APA
C, Z., W, Z., Q, M., N, L., J, W., B, L., H, W., X, W., S, G., J, W., X, S., Y, L., & X, Q. (2022). Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.. Annals of translational medicine. https://doi.org/10.21037/atm-22-5632
Source records
- pubmed · retrieved 2026-09-25T11:03:45.245Z